These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 28070849)

  • 1. Investigation into the Manufacture and Properties of Inhalable High-Dose Dry Powders Produced by Comilling API and Lactose with Magnesium Stearate.
    Lau M; Young PM; Traini D
    AAPS PharmSciTech; 2017 Aug; 18(6):2248-2259. PubMed ID: 28070849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-milled API-lactose systems for inhalation therapy: impact of magnesium stearate on physico-chemical stability and aerosolization performance.
    Lau M; Young PM; Traini D
    Drug Dev Ind Pharm; 2017 Jun; 43(6):980-988. PubMed ID: 28122460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigations on the Mechanism of Magnesium Stearate to Modify Aerosol Performance in Dry Powder Inhaled Formulations.
    Jetzer MW; Schneider M; Morrical BD; Imanidis G
    J Pharm Sci; 2018 Apr; 107(4):984-998. PubMed ID: 29247741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limitations of high dose carrier based formulations.
    Yeung S; Traini D; Tweedie A; Lewis D; Church T; Young PM
    Int J Pharm; 2018 Jun; 544(1):141-152. PubMed ID: 29649519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of dispersion enhancer selection in the development of novel tratinterol hydrochloride dry powder inhalation formulations.
    Liu T; Tong S; Liao Q; Pan L; Cheng M; Rantanen J; Cun D; Yang M
    Int J Pharm; 2023 Mar; 635():122702. PubMed ID: 36773729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlations between surface composition and aerosolization of jet-milled dry powder inhaler formulations with pharmaceutical lubricants.
    Mangal S; Park H; Nour R; Shetty N; Cavallaro A; Zemlyanov D; Thalberg K; Puri V; Nicholas M; Narang AS; Zhou QT
    Int J Pharm; 2019 Sep; 568():118504. PubMed ID: 31299339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergistic effect of magnesium stearate and fine lactose in improving aerosolization performance of fluticasone propionate in dry powder formulation.
    He X; Li J; Wen X; Ma S; An Y; Zhang X; Guan J; Mao S
    Int J Pharm; 2024 Oct; 664():124609. PubMed ID: 39163928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of magnesium stearate surface coating method on the aerosol performance and permeability of micronized fluticasone propionate.
    Kumar V; Sethi B; Yanez E; Leung DH; Ghanwatkar YY; Cheong J; Tso J; Narang AS; Nagapudi K; Mahato RI
    Int J Pharm; 2022 Mar; 615():121470. PubMed ID: 35041913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dispersibility of lactose fines as compared to API in dry powders for inhalation.
    Thalberg K; Åslund S; Skogevall M; Andersson P
    Int J Pharm; 2016 May; 504(1-2):27-38. PubMed ID: 26965200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of fine lactose and magnesium stearate on low dose dry powder inhaler formulations.
    Guchardi R; Frei M; John E; Kaerger JS
    Int J Pharm; 2008 Feb; 348(1-2):10-7. PubMed ID: 17689898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the influence of magnesium stearate content and mixing modality on the rheological properties and in vitro aerosolization of dry powder inhaler.
    Li J; Ma S; He X; Sun Y; Zhang X; Guan J; Mao S
    Int J Pharm; 2023 Jul; 642():123179. PubMed ID: 37364785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dry powder inhalers: mechanistic evaluation of lactose formulations containing salbutamol sulphate.
    Kaialy W; Ticehurst M; Nokhodchi A
    Int J Pharm; 2012 Feb; 423(2):184-94. PubMed ID: 22197772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of surface coating with magnesium stearate via mechanical dry powder coating approach on the aerosol performance of micronized drug powders from dry powder inhalers.
    Zhou QT; Qu L; Gengenbach T; Larson I; Stewart PJ; Morton DA
    AAPS PharmSciTech; 2013 Mar; 14(1):38-44. PubMed ID: 23196863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preparation and Evaluation of Surface Modified Lactose Particles for Improved Performance of Fluticasone Propionate Dry Powder Inhaler.
    Singh DJ; Jain RR; Soni PS; Abdul S; Darshana H; Gaikwad RV; Menon MD
    J Aerosol Med Pulm Drug Deliv; 2015 Aug; 28(4):254-67. PubMed ID: 25517187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of the surface energy of lubricated pharmaceutical powders by inverse gas chromatography.
    Swaminathan V; Cobb J; Saracovan I
    Int J Pharm; 2006 Apr; 312(1-2):158-65. PubMed ID: 16469458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ternary Dry Powder Agglomerate Inhalation Formulation of Melatonin With Air Jet Mixing to Improve In Vitro And In Vivo Performance.
    Zhang Q; Kou S; Cui Y; Dong J; Ye Y; Wang Y; Lu R; Li X; Nie Y; Shi K; Chen F; Hall P; Chen X; Wang Z; Jiang X
    J Pharm Sci; 2024 Feb; 113(2):434-444. PubMed ID: 37995838
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance tuning of particle engineered mannitol in dry powder inhalation formulations.
    Hertel N; Birk G; Scherließ R
    Int J Pharm; 2020 Aug; 586():119592. PubMed ID: 32622814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-loading cannabidiol powders for inhalation.
    Tai W; Yau GTY; Arnold JC; Chan HK; Kwok PCL
    Int J Pharm; 2024 Jul; 660():124370. PubMed ID: 38906498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the particulate microstructure of the aerodynamic particle size distribution of dry powder inhaler combination products.
    Jetzer MW; Morrical BD; Schneider M; Edge S; Imanidis G
    Int J Pharm; 2018 Mar; 538(1-2):30-39. PubMed ID: 29289516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of high shear blending on distribution of magnesium stearate on lactose for dry powder inhaled formulations.
    Welle A; Mehta M; Marek K; Peters H; van der Wel P; Imole O
    Int J Pharm; 2023 Nov; 647():123503. PubMed ID: 37827391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.